1
                                                                      EXHIBIT 99


Biomune Systems, Inc. Announces the Transfer of Certain Assets by Donlar
Corporation

BEDFORD PARK, Ill., January 19, 2001 - Biomune Systems, Inc. (BIME:OTC)
("Biomune") announced that its parent, Donlar Corporation ("Donlar"),
transferred all of Donlar's assets and associated liabilities, excluding those
related to Donlar's existing patent rights and all intellectual property
relating to its genetic (recombinant DNA) research activities, to Biomune as a
capital contribution. The transfer took place following a meeting of the
shareholders of Donlar where the transfer was approved and was pursuant to a
Capital Contribution, Assignment and Assumption Agreement dated January 19, 2001
between Donlar and Biomune.

As a result of the foregoing transaction, all of Donlar's operational
activities, except for its genetic research activities, will be conducted by
Biomune. Biomune's administrative, marketing, sales and distribution operations
will be conducted from Donlar's headquarters in Bedford Park, Illinois, and its
manufacturing operations will be conducted from Donlar's Peru, Illinois
facility, which has been transferred to Biomune.

Biomune's reorganized businesses will be conducted through four business
segments:

         -   BioPolymers, consisting of the performance chemicals business
             acquired from Donlar;
         -   AgriSciences, consisting of the agricultural businesses acquired
             from Donlar;
         -   Pharmaceuticals, consisting of the pharmaceutical research and
             development activities of both Donlar and Biomune; and
         -   Optim Nutrition, consisting of Biomune's nutritional and
             nutraceuticals business.

Donlar Corporation, founded in 1990 and based in Bedford Park, Illinois, is a
diversified biotech and biopolymer company that has developed a wide range of
patented protein products for use in industrial, agricultural, consumer and
pharmaceutical markets. Donlar was the recipient of the EPA's first Presidential
Green Chemistry Challenge Award for its work in the development of
environmentally responsible products and manufacturing processes.
(www.donlar.com)

Biomune Systems, Inc., a Nevada corporation, with its wholly owned subsidiary,
Optim Nutrition, Inc., is engaged in the distribution and sale of biologic
nutraceutical supplements and sports and nutrition bars.
(www.optimnutrition.com)

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Actual results could differ materially from those
projected in the forward-looking statements, which involve a number of risks and
uncertainties. The contents of this release should be considered in conjunction
with the warnings and cautionary statements contained in Biomune's most recent
filings with the Securities and Exchange Commission on Forms 10-QSB and 10-KSB
and current reports on Form 8-K.

For further information contact Larry P. Koskan of Biomune Systems, Inc. at
(708) 563-9200.